Skip to main content

TransUnion Stock Gains 6% Post Reporting Q4 Earnings & Revenue Beat

Zacks Investment Research - Thu Feb 19, 10:42AM CST
TransUnion Stock Gains 6% Post Reporting Q4 Earnings & Revenue Beat

TransUnion TRU reported impressive fourth-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.

TRU’s quarterly adjusted EPS (adjusting 55 cents from non-recurring items) of $1.07 surpassed the consensus mark by 3.9%. The metric grew 10.3% year over year. Total revenues of $1.2 billion beat the consensus mark by 3% and rose 13% from the year-ago quarter.

The better-than-expected results impressed the market as the stock gained 5.5% since the release of results on Feb. 12, 2026.

Over the past year, the TRU stock has declined 19.4% compared with the 27.2% fall of the industry it belongs to and against 15.7% growth of the Zacks S&P 500 Composite.

TransUnion Price, Consensus and EPS Surprise

TransUnion Price, Consensus and EPS Surprise

TransUnion price-consensus-eps-surprise-chart | TransUnion Quote

TransUnion’s Revenues by Segments

The U.S. Markets segment’s revenues of $918.9 million increased 16% year over year. It failed to beat the Zacks Consensus Estimate for revenues of $921 million. Within the segment, financial services’ revenues of $423.1 million grew 16% from the year-ago quarter. Emerging vertical revenues were $350 million, up 9% year over year. Consumer Interactive revenues were $145.5 million, up 9% from the year-ago quarter.

The international segment logged revenues of $255.9 million, up 4% from the year-ago quarter. The metric is lower than the consensus mark for revenues of $274.2 million. Within this segment, Canada and Latin America registered $43.5 million and $34.8 million in revenues, increasing 13% and 3% year over year, respectively. On a constant-currency (cc) basis, revenues from Canada rose 13% from the year-ago quarter, while Latin America witnessed a 3% dip. Revenues from the U.K. gained 22% year over year on a reported basis and 18% on a cc basis to $72.2 million.

The Africa and India regions recorded revenues of $19.6 million and $60.4 million, respectively. For Africa, the reported revenue growth rate is 7% year over year and 3% on a cc basis. A 9% year-over-year dip in revenues on a reported basis was recorded for the India region, and a 4% dip was observed on a cc basis. Revenues from the Asia Pacific region were $25.4 million, down 11% year over year on a reported and cc basis.

TRU’s Operating Performance

Adjusted EBITDA was $417 million, marking year-over-year growth of 10% on both reported and cc basis. The adjusted EBITDA margin was 35.6%, down 90 basis points from the year-ago quarter.

For the United States and international market, TRU recorded adjusted EBITDA of $348.5 million and $255.9 million, gaining 12% and 4% year over year on a reported and cc basis, respectively. Adjusted EBITDA from the U.S. market missed the Zacks Consensus Estimate of $349.1 million, while the international market surpassed the consensus mark of $124.8 million.

Balance Sheet & Cash Flow of TRU

TransUnion had $853.6 million in cash and cash equivalents at the end of the quarter compared with $749.9 million at the end of the third quarter of 2025. The long-term debt was $4.9 billion compared with $5 billion in the preceding quarter.

Cash generated from operating activities in the quarter was $319.5 million. Capital expenditure was $96.7 million.

TransUnion’s Q1 & 2026 Outlook

For the first quarter of 2026, TransUnion expects revenues of $1.195-$1.205 billion. The mid-point ($1.2 billion) of the guided range meets the current consensus estimate. TRU expects adjusted EPS between $1.08-$1.10. The guided range is lower than the Zacks Consensus Estimate of $1.14. The guidance for the adjusted EBITDA is kept at $414-$420 million.

For 2026, TransUnion expects revenues of $4.946-$4.981 billion. The mid-point ($4.964 billion) of the guided range is slightly lower than the Zacks Consensus Estimate of $4.97 billion.

TRU expects adjusted EPS of $4.63-$4.71. The guided range is lower than the Zacks Consensus Estimate of $4.85. The adjusted EBITDA outlook is at $1.756-$1.777 billion.

TRU has a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Earnings Snapshot

IQVIA Holdings Analytics Inc. IQV has reported impressive fourth-quarter 2025 results.

Adjusted earnings were $3.42 per share, surpassing the Zacks Consensus Estimate by a slight margin and gaining 9.6% on a year-over-year basis. Total revenues of $4.4 billion beat the consensus estimate by 2.8% and rose 10.1% from the year-ago quarter.

Equifax Inc. EFX has reported impressive fourth-quarter 2025 results.

EFX posted $2.09 in EPS, beating the Zacks Consensus Estimate by 2.2%. This marked a 1.4% dip from the fourth quarter of 2025. The company recorded $1.6 billion in its top line, surpassing the consensus estimate by 1.3%. Revenues spiked 9.1% from the year-ago quarter’s actual.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Equifax, Inc. (EFX): Free Stock Analysis Report
 
TransUnion (TRU): Free Stock Analysis Report
 
IQVIA Holdings Inc. (IQV): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.